UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051398
Receipt number R000058637
Scientific Title A retrospective observational study of the occurrence of pneumothorax and/or pneumomediastinum in patients with interstitial lung diseases treated with antifibrotic drugs
Date of disclosure of the study information 2023/06/21
Last modified on 2023/06/21 11:22:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A retrospective observational study of the occurrence of pneumothorax and/or pneumomediastinum in patients with interstitial lung diseases treated with antifibrotic drugs

Acronym

Pneumothorax and/or pneumomediastinum in patients with interstitial lung diseases treated with antifibrotic drugs

Scientific Title

A retrospective observational study of the occurrence of pneumothorax and/or pneumomediastinum in patients with interstitial lung diseases treated with antifibrotic drugs

Scientific Title:Acronym

Pneumothorax and/or pneumomediastinum in patients with interstitial lung diseases treated with antifibrotic drugs

Region

Japan


Condition

Condition

interstitial lung disease

Classification by specialty

Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the development of pneumothorax and/or pneumomediastinum in patients with interstitial lung diseases treated with antifibrotic drugs, and to determine whether antifibrotic drugs administration is associated with refractory pneumothorax and pneumomediastinum.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Incidence of pneumothorax and/or pneumomediastinum in patients with interstitial lung diseases treated with antifibrotic drugs

Key secondary outcomes

Rate of refractory pneumothorax and/or pneumomediastinum in patients with interstitial lung diseases treated with antifibrotic drugs


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with interstitial lung diseases who received the antifibrotic drugs, nintedanib or pirfenidone, at Kochi University Hospital from December 1, 2008 to September 30, 2022

Key exclusion criteria

None

Target sample size

70


Research contact person

Name of lead principal investigator

1st name Hiroshi
Middle name
Last name Ohnishi

Organization

Kochi Medical School, Kochi University

Division name

Department of Respiratory Medicine and Allergology

Zip code

783-8505

Address

Kohasu 185-1, Oko-Cho, Nankoku, Kochi, Japan

TEL

088-880-2345

Email

honi@kochi-u.ac.jp


Public contact

Name of contact person

1st name Hiroshi
Middle name
Last name Ohnishi

Organization

Kochi Medical School, Kochi University

Division name

Department of Respiratory Medicine and Allergology

Zip code

783-8505

Address

Kohasu 185-1, Oko-Cho, Nankoku, Kochi, Japan

TEL

088-880-2345

Homepage URL


Email

honi@kochi-u.ac.jp


Sponsor or person

Institute

Kochi Medical School, Kochi University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The ethical review board of Kochi Medical School

Address

Kohasu 185-1, Oko-Cho, Nankoku, Kochi, Japan

Tel

088-880-2180

Email

is21@kochi-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

高知大学医学部附属病院


Other administrative information

Date of disclosure of the study information

2023 Year 06 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

70

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2022 Year 11 Month 10 Day

Date of IRB

2023 Year 01 Month 04 Day

Anticipated trial start date

2023 Year 01 Month 04 Day

Last follow-up date

2023 Year 06 Month 21 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Patient information (sex, age, height, weight, BMI, smoking history), Type of interstitial lung diseases, age at onset of interstitial lung diseases, history of corticosteroid administration, history of acute exacerbations, antifibrotic drugs (type, dosage, duration of administration), respiratory function test results, blood test results (albumin, HbA1c, CRP, LDH, KL-6, SP-A, SP-D ), chest high-resolution CT findings, presence or absence of home oxygen therapy, presence or absence of pneumothorax or pneumomediastinum (before, during, and after discontinuation of antifibrotic therapy), number of days until pneumothorax or pneumomediastinum heals, treatment for pneumothorax, and survival.


Management information

Registered date

2023 Year 06 Month 21 Day

Last modified on

2023 Year 06 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000058637


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name